The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Top Cited Papers
- 1 February 2003
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 3 (2) , 185-197
- https://doi.org/10.1016/s1535-6108(03)00028-x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphomaBlood, 2002
- Mantle-cell lymphomaThe Lancet Oncology, 2001
- The use of real-time quantitative polymerase chain reaction and comparative genomic hybridization to identify amplification of the REL gene in follicular lymphomaBritish Journal of Haematology, 2000
- t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemiaGenes, Chromosomes and Cancer, 2000
- Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesisGenes & Development, 1999
- The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locusNature, 1999
- The Lymphochip: A Specialized cDNA Microarray for the Genomic-scale Analysis of Gene Expression in Normal and Malignant LymphocytesCold Spring Harbor Symposia on Quantitative Biology, 1999
- Mantle cell lymphomaCancer, 1998
- PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphomaBlood, 1994
- LII. An essay towards solving a problem in the doctrine of chances. By the late Rev. Mr. Bayes, F. R. S. communicated by Mr. Price, in a letter to John Canton, A. M. F. R. SPhilosophical Transactions of the Royal Society of London, 1763